Javascript must be enabled to continue!
Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation
View through CrossRef
AbstractIn Cystic Fibrosis (CF), mucus plaques are formed in the patient’s lung, creating a hypoxic condition and a propitious environment for colonization and persistence of many microorganisms. There is clinical evidence showing that Aspergillus fumigatus can co-colonize CF patients with Pseudomonas aeruginosa, which has been associated with lung function decline. P. aeruginosa produces several compounds with inhibitory and anti-biofilm effects against A. fumigatus in vitro; however, little is known about the fungal compounds produced in counterattack. Here, we annotated fungal and bacterial secondary metabolites (SM) produced in mixed biofilms in normoxia and hypoxia conditions. We detected nine SMs produced by P. aeruginosa. Phenazines and different analogs of pyoverdin were the main compounds produced by P. aeruginosa, and their secretion were increased by the fungal presence. The roles of the two operons responsible for phenazines production (phzA1 and phzA2) were also investigated showing both mutants are able to produce partial sets of phenazines. We detected a total of 20 SMs secreted by A. fumigatus either in monoculture or in co-culture with P. aeruginosa. All these compounds are secreted during biofilm formation either in normoxia or hypoxia. However, only eight compounds (demethoxyfumitremorgin C, fumitremorgin, ferrichrome, ferricrocin, tricetylfusigen, gliotoxin, gliotoxin E, and pyripyropene A) were detected during the biofilm formation by the co-culture of A. fumigatus and P. aeruginosa upon both normoxia and hypoxia conditions. Overall, we showed how diverse is SM secretion during A. fumigatus and P. aeruginosa mixed culture and how this can affect biofilm formation both in normoxia and hypoxia.Author SummaryThe interaction between Pseudomonas aeruginosa and Aspergillus fumigatus has been well-characterized in vitro. In this scenario, the bacterium exerts a strong inhibitory effect against the fungus. However, little is known about the metabolites produced by the fungus to counterattack the bacteria. Our work aimed to annotate secondary metabolites (SM) secreted during co-culture between P. aeruginosa and A. fumigatus during biofilm formation in both normoxia and hypoxia. The bacterium produces several different types of phenazines and pyoverdins, in response to the fungus presence. In contrast, we were able to annotate 29 metabolites produced during A. fumigatus biofilm formation but only eight compounds were detected during biofilm formation by the co-culture of A. fumigatus and P. aeruginosa upon both normoxia and hypoxia. In conclusion, we have detected many SMs secreted during A. fumigatus and P. aeruginosa biofilm formation. This analysis can provide several opportunities to understand the interaction between these two species.
Title: Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation
Description:
AbstractIn Cystic Fibrosis (CF), mucus plaques are formed in the patient’s lung, creating a hypoxic condition and a propitious environment for colonization and persistence of many microorganisms.
There is clinical evidence showing that Aspergillus fumigatus can co-colonize CF patients with Pseudomonas aeruginosa, which has been associated with lung function decline.
P.
aeruginosa produces several compounds with inhibitory and anti-biofilm effects against A.
fumigatus in vitro; however, little is known about the fungal compounds produced in counterattack.
Here, we annotated fungal and bacterial secondary metabolites (SM) produced in mixed biofilms in normoxia and hypoxia conditions.
We detected nine SMs produced by P.
aeruginosa.
Phenazines and different analogs of pyoverdin were the main compounds produced by P.
aeruginosa, and their secretion were increased by the fungal presence.
The roles of the two operons responsible for phenazines production (phzA1 and phzA2) were also investigated showing both mutants are able to produce partial sets of phenazines.
We detected a total of 20 SMs secreted by A.
fumigatus either in monoculture or in co-culture with P.
aeruginosa.
All these compounds are secreted during biofilm formation either in normoxia or hypoxia.
However, only eight compounds (demethoxyfumitremorgin C, fumitremorgin, ferrichrome, ferricrocin, tricetylfusigen, gliotoxin, gliotoxin E, and pyripyropene A) were detected during the biofilm formation by the co-culture of A.
fumigatus and P.
aeruginosa upon both normoxia and hypoxia conditions.
Overall, we showed how diverse is SM secretion during A.
fumigatus and P.
aeruginosa mixed culture and how this can affect biofilm formation both in normoxia and hypoxia.
Author SummaryThe interaction between Pseudomonas aeruginosa and Aspergillus fumigatus has been well-characterized in vitro.
In this scenario, the bacterium exerts a strong inhibitory effect against the fungus.
However, little is known about the metabolites produced by the fungus to counterattack the bacteria.
Our work aimed to annotate secondary metabolites (SM) secreted during co-culture between P.
aeruginosa and A.
fumigatus during biofilm formation in both normoxia and hypoxia.
The bacterium produces several different types of phenazines and pyoverdins, in response to the fungus presence.
In contrast, we were able to annotate 29 metabolites produced during A.
fumigatus biofilm formation but only eight compounds were detected during biofilm formation by the co-culture of A.
fumigatus and P.
aeruginosa upon both normoxia and hypoxia.
In conclusion, we have detected many SMs secreted during A.
fumigatus and P.
aeruginosa biofilm formation.
This analysis can provide several opportunities to understand the interaction between these two species.
Related Results
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Abstract
Introduction: Pleural empyema is the collection of pus within the pleural cavity, typically arising as a complication of pneumonia, chest trauma, thoracic surgery, or bact...
Counterclockwise rotation of the flagellum promotes biofilm initiation in
Helicobacter pylori
Counterclockwise rotation of the flagellum promotes biofilm initiation in
Helicobacter pylori
ABSTRACT
Motility promotes biofilm initiation during the early steps of this process: microbial surface association and attachmen...
Metallothionein Protein Modeling from Pseudomonas aeruginosa PAO1 as A Metal Biosorber Candidate
Metallothionein Protein Modeling from Pseudomonas aeruginosa PAO1 as A Metal Biosorber Candidate
Metallothionein is a protein that is well known to play a role in metal metabolism in bacterial cells. Metallothionein is a multifunctional protein that has the potential to be use...
Optogenetic Modulation of a Productive Biofilm for Improved Biotransformation
Optogenetic Modulation of a Productive Biofilm for Improved Biotransformation
<p>Biofilm as a living catalysts has been exploited for the production of biofuels and bioelectricity in microbial fuel cells (MFCs) as well as in the synthesis of bu...
Prevalence and risk factors of
Pseudomonas aeruginosa
colonization
Prevalence and risk factors of
Pseudomonas aeruginosa
colonization
Abstract
Pseudomonas aeruginosa
(
P. aeruginosa
) is one of the most concerning pathogens d...
Role of NaCl and Glutamine on Biofilm Production from Pseudomonas aeruginosa
Role of NaCl and Glutamine on Biofilm Production from Pseudomonas aeruginosa
Pseudomonas aeruginosa is an opportunistic pathogen capable of forming antibiotic-resistant biofilms, contributing to persistent infections and treatment failure. Environmental fac...
Combinatorial control of
Pseudomonas aeruginosa
biofilm development by quorum-sensing and nutrient-sensing regulators
Combinatorial control of
Pseudomonas aeruginosa
biofilm development by quorum-sensing and nutrient-sensing regulators
ABSTRACT
The human pathogen
Pseudomonas aeruginosa
, a leading cause of hospital-acquired infections,...
Chronic Superficial Infection in a Dog caused by Multidrug-Resistant Pseudomonas aeruginosa
Chronic Superficial Infection in a Dog caused by Multidrug-Resistant Pseudomonas aeruginosa
Background: Pseudomonas aeruginosa is a gram-negative aerobic bacterium and non-glucose fermenting, that usuallycauses opportunistic infections in animals, including humans. It is ...

